Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis - PubMed (original) (raw)
. 2014 Nov;1842(11):2204-15.
doi: 10.1016/j.bbadis.2014.08.015. Epub 2014 Sep 6.
Affiliations
- PMID: 25201080
- DOI: 10.1016/j.bbadis.2014.08.015
Free article
Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis
Yong He et al. Biochim Biophys Acta. 2014 Nov.
Free article
Abstract
Long noncoding RNAs (lncRNAs) are being increasingly recognized as major players in governing fundamental biological processes through diverse mechanisms. Maternally expressed gene 3 (MEG3) is an imprinted gene located at 14q32 that encodes a lncRNA correlated with several human cancers. Recently, the methylation-dependent downregulation of MEG3 has been described in liver cancers. However, its biological functional role in liver fibrosis remains unknown. In our study, MEG3 levels were remarkably decreased in CCl4-induced mouse liver fibrosis models and human fibrotic livers as demonstrated by real-time quantitative PCR. Moreover, the expression of MEG3 was downregulated in human hepatic stellate cell lines LX-2 cells in response to transforming growth factor-β1 (TGF-β1) stimulation in dose and time-dependent manner. Enforced expression of MEG3 in LX-2 cells inhibited TGF-β1-induced cell proliferation, while promoting cell apoptosis. In addition, hypermethylation of MEG3 promoter was identified by methylation-specific PCR and MEG3 expression was robustly increased by the inhibition of methylation with either 5-aza-2-deoxycytidine (5-azadC), or siRNA to DNA methyltransferase 1 (DNMT1) in TGF-β1-induced LX-2 cells. More importantly, overexpression of MEG3 could activate p53 and mediate cytochrome c release, subsequently leading to caspase-3-dependent apoptosis in TGF-β1-treated LX-2 cells. These findings suggested that MEG3 may play an important role in stellate cell activation and liver fibrosis progression and act as a novel potential therapeutic target for liver fibrosis.
Keywords: Liver fibrosis; MEG3; Methylation; lncRNAs; p53.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
- Hotair facilitates hepatic stellate cells activation and fibrogenesis in the liver.
Bian EB, Wang YY, Yang Y, Wu BM, Xu T, Meng XM, Huang C, Zhang L, Lv XW, Xiong ZG, Li J. Bian EB, et al. Biochim Biophys Acta Mol Basis Dis. 2017 Mar;1863(3):674-686. doi: 10.1016/j.bbadis.2016.12.009. Epub 2016 Dec 13. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 27979710 - miR-185 affected the EMT, cell viability, and proliferation via DNMT1/MEG3 pathway in TGF-β1-induced renal fibrosis.
Xue R, Li Y, Li X, Ma J, An C, Ma Z. Xue R, et al. Cell Biol Int. 2019 Oct;43(10):1152-1162. doi: 10.1002/cbin.11046. Epub 2019 Jul 21. Cell Biol Int. 2019. PMID: 30095214 - Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
Wu Y, Liu X, Zhou Q, Huang C, Meng X, Xu F, Li J. Wu Y, et al. Toxicol Appl Pharmacol. 2015 Dec 1;289(2):163-76. doi: 10.1016/j.taap.2015.09.028. Epub 2015 Oct 3. Toxicol Appl Pharmacol. 2015. PMID: 26435214 - Potential applications of MEG3 in cancer diagnosis and prognosis.
He Y, Luo Y, Liang B, Ye L, Lu G, He W. He Y, et al. Oncotarget. 2017 Aug 4;8(42):73282-73295. doi: 10.18632/oncotarget.19931. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069869 Free PMC article. Review. - MEG3 noncoding RNA: a tumor suppressor.
Zhou Y, Zhang X, Klibanski A. Zhou Y, et al. J Mol Endocrinol. 2012 Apr 2;48(3):R45-53. doi: 10.1530/JME-12-0008. Print 2012 Jun. J Mol Endocrinol. 2012. PMID: 22393162 Free PMC article. Review.
Cited by
- LncRNAs in TGF-β-Driven Tissue Fibrosis.
Tang PM, Zhang YY, Lan HY. Tang PM, et al. Noncoding RNA. 2018 Oct 4;4(4):26. doi: 10.3390/ncrna4040026. Noncoding RNA. 2018. PMID: 30287731 Free PMC article. Review. - Expression and function of long non-coding RNA LINC01420 in thyroid cancer.
Luo JZ, Qin L, Zhang LJ. Luo JZ, et al. Oncol Lett. 2020 Jan;19(1):399-405. doi: 10.3892/ol.2019.11076. Epub 2019 Nov 11. Oncol Lett. 2020. PMID: 31897152 Free PMC article. - MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.
Al-Rugeebah A, Alanazi M, Parine NR. Al-Rugeebah A, et al. Pathol Oncol Res. 2019 Jul;25(3):859-874. doi: 10.1007/s12253-019-00614-3. Epub 2019 Feb 21. Pathol Oncol Res. 2019. PMID: 30793226 Review. - Regulatory long non-coding RNAs of hepatic stellate cells in liver fibrosis (Review).
Wu Z, Huang S, Zheng X, Gu S, Xu Q, Gong Y, Zhang J, Fu B, Tang L. Wu Z, et al. Exp Ther Med. 2021 Apr;21(4):351. doi: 10.3892/etm.2021.9782. Epub 2021 Feb 11. Exp Ther Med. 2021. PMID: 33732324 Free PMC article. Review. - Concise Review: Functional Roles and Therapeutic Potentials of Long Non-coding RNAs in Cholangiopathies.
Sato K, Glaser S, Francis H, Alpini G. Sato K, et al. Front Med (Lausanne). 2020 Feb 20;7:48. doi: 10.3389/fmed.2020.00048. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32154257 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous